Baidu
map

BMJ:加压袜辅助静脉血栓预防的效果不显著

2020-05-14 MedSci原创 MedSci原创

对于择期手术的中高静脉血栓风险患者,在药物预防的基础上使用分级加压袜辅助治疗的效果不显著

近日研究人员考察了使用分级加压袜(GCS)用于药物血栓预防的辅助效果。
 
1905名择期外科住院患者患者参与研究,静脉血栓栓塞风险为中度或高度,在低分子肝素(LMWH)药物血栓预防基础上,随机使用GCS或对照。研究的主要结果是影像学证实下肢深静脉血栓或术后90天内肺栓塞症状。次要的结果指标是生活质量、对GCS和LMWH的依从性、与GCS相关的下肢并发症、出血并发症、LMWH的不良反应以及所有原因死亡率。
 
1858名患者参与研究,单纯LMWH治疗组937例患者中有16例(1.7%)出现主要预后事件,而LMWH联合GCS组921例患者中有13例(1.4%)出现主要预后事件。两组之间的风险差异为0.30%。
 
研究认为,对于择期手术的中高静脉血栓风险患者,在药物预防的基础上使用分级加压袜辅助治疗的效果不显著。
 
原始出处:
 
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-10-24 gaoxiaoe
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-07-30 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2021-04-06 fusion
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1650199, encodeId=e3bd165019951, content=<a href='/topic/show?id=0f31329e0f6' target=_blank style='color:#2F92EE;'>#加压袜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32970, encryptionId=0f31329e0f6, topicName=加压袜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76be23986320, createdName=bnjfx@134.com, createdTime=Mon Apr 26 20:13:46 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849023, encodeId=500818490230d, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Oct 24 15:13:46 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955491, encodeId=2703195549154, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Thu Jul 30 04:13:46 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698098, encodeId=5bbf1698098b1, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Apr 06 18:13:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516241, encodeId=296715162410c, content=<a href='/topic/show?id=9fc98913163' target=_blank style='color:#2F92EE;'>#血栓预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89131, encryptionId=9fc98913163, topicName=血栓预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ca010933746, createdName=12498cf9m38(暂无昵称), createdTime=Sat May 16 10:13:46 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047062, encodeId=2788104e062d5, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu May 14 22:13:46 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

JAMA Surg:急诊手术患者静脉血栓栓塞风险增加

与择期手术相比,急诊患者的静脉血栓栓塞风险增加,特别是对于高侵入性手术患者

Gastroenterology:胰腺导管腺癌需警惕静脉血栓的发生

胰腺导管腺癌断后静脉血栓栓塞早期发作或频发导致患者预后较差,需要进行研究以确定PDAC患者的VTE初级预防是否会改善与VTE相关的发病率和死亡率

JAMA Intern Med:睾酮治疗增加男性静脉血栓风险

睾酮治疗与男性短期VTE风险增加相关,年轻男性的风险尤为显著

Blood:抗凝血酶替代预防静脉血栓栓塞的效果

强化抗凝血酶和肝素预防并不能百分比地预防VTE的发生。 纤维蛋白原浓缩物可增加血栓形成风险,应限制用于出血患者。

医院如何大幅提升VTE防治效率?1800余位专家达成这一共识……

在临床VTE防治过程中,最让医生和护士头痛的难题是什么?在最近的中国VTE防治大会上,面对来自全国各地的1800余位医护专家,一项问卷调查悄然进行着……

JACC:心衰的住院会增加患者远期静脉血栓风险

心衰住院可能增加患者短期静脉血栓(VTE)的风险,长期的VTE风险与心衰的发生、心衰的亚型或结构性心脏病的关系尚不清楚。本研究的目的旨在ARIC队列中评估VTE风险与心衰的发生、心衰的亚型和异常心超参数的关系。本研究纳入分析了13728名患者,经过平均22年时间的随访,有2696名(20%)患者发展为心衰,729名后面发展为VTE。心衰可增加长期的VTE发生风险。在7588名随访了10年的患者中,

Baidu
map
Baidu
map
Baidu
map